Yazji Salim

Insider profile

Performance

Overall performance
2.5

Performance over holding periods
2.5
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Yazji Salim's trades of Oncternal Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-10-15 2024-10-14 PrS Proposed sale
52,283
278.52
US$3,385,006
52,283 278.52 US$3,385,006
2023-04-14 2023-04-14 B Purchase
22,557 +19.3%
152.41
US$3,130,083
22,557 +19.3% 152.41 US$3,130,083
2023-04-14 2023-04-13 B Purchase
80,280 +19.1%
115.98
US$129,509
80,280 +19.1% 115.98 US$129,509
2023-04-14 2023-04-12 B Purchase
10,000 +7.2%
0.29
US$2,850
10,000 +7.2% 0.29 US$2,850
2022-01-31 2022-01-27 B Purchase
10,000 +17.5%
1.69
US$16,900
10,000 +17.5% 1.69 US$16,900